Nasdaq · CIK 0001819253
BTMD biote Corp.
Insider trading from SEC Form 4. Last filing Aug 12, 2026. Close $1.15 on Oct 9, 2026, +4% from the 52-week low and -64% from the high.
biote Corp. (BTMD) has 36 SEC Form 4 filings on file from 12 insiders, the latest filed on Aug 12, 2026. In the last 90 days insiders made 1 open-market buy worth $202k and 0 open-market sells worth $0, net +$202k.
14 open-market trades have been scored at BTMD. The newest: Marc D Beer (Executive Chairman) bought $202k of stock on Aug 10, 2026, filed Aug 12, 2026, scored 50 (moderate). The largest of the 14 shown: Guines LLC (10% owner) bought $2.8M on Mar 13, 2025, scored 71 (notable). 5 insiders bought within 14 days of each other around Mar 13, 2025.
BTMD closed at $1.15 on Oct 9, 2026, 4% above its 52-week low and 64% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at biote Corp., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Marc D Beer Executive Chairman buy | $202k 131,950 shares | +122% | +18% from low-56% from high | |
| 58Moderate | Guines LLC owner buy | $1.5M 447,714 shares | +11% | +10% from low-51% from high | |
| 25Weak | Guines LLC owner buy | $6,371 1,933 shares | +0% | +8% from low-52% from high | |
| 20Weak | Guines LLC owner buy | $29k 8,801 shares | +0% | +11% from low-51% from high | |
| 30Weak | Guines LLC owner buy | $26k 7,874 shares | +0% | +8% from low-52% from high | |
| 41Moderate | Guines LLC owner buy | $155k 48,439 shares | +1% | +6% from low-53% from high | |
| 43Moderate | Guines LLC owner buy | $237k 74,440 shares | +2% | +9% from low-52% from high | |
| 71Notable | Guines LLC owner buy | $2.8M 856,609 shares | +28% | 0% from low-56% from high | |
| 60Notable | Guines LLC owner buy | $352k 106,000 shares | +3% | +8% from low-52% from high | |
| 55Moderate | Andrew R Heyer director buy | $296k 75,000 shares | +5% | +30% from low-42% from high | |
| 62Notable | Marc D Beer Executive Chairman buy | $417k 107,794 shares | - | +30% from low-42% from high | |
| 67Notable | Bret Christensen Chief Executive Officer buy | $145k 37,595 shares | - | +30% from low-42% from high | |
| 55Moderate | Stephen Mark Cone director buy | $148k 38,104 shares | +31% | +30% from low-42% from high | |
| 71Notable | Guines LLC owner buy | $2.8M 856,609 shares | +28% | 0% from low-56% from high |
Transactions
The newest 50 of 61 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Marc D Beer Executive Chairman | POpen-market purchase Class A Common Stock | +115,950 | $1.53 | $177k | 223,744 | Aug 12, 2026 |
| Aug 11, 2026 | Marc D Beer Executive Chairman | POpen-market purchase Class A Common Stock | +16,000 | $1.55 | $25k | 239,744 | Aug 12, 2026 |
| Jun 12, 2026 | Robert Charles Peterson Interim CEO | AGrant or award Stock Options (Right to buy)derivative | +206,746 | $0.00 | $0 | 206,746 | Jun 16, 2026 |
| Jun 8, 2026 | Bret Christensen Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +130,000 | $0.00 | $0 | 130,000 | Jun 10, 2026 |
| Jun 8, 2026 | Marc D Beer Executive Chairman | AGrant or award Employee Stock Option (Right to Buy)derivative | +114,157 | $0.00 | $0 | 114,157 | Jun 10, 2026 |
| May 12, 2026 | Andrew R Heyer director | AGrant or award Deferred Settlement RSUderivative | +35,259 | $0.00 | $0 | 81,382 | May 14, 2026 |
| May 12, 2026 | Andrew R Heyer director | AGrant or award Stock Option (Right to Buy)derivative | +130,000 | $0.00 | $0 | 130,000 | May 14, 2026 |
| May 12, 2026 | Stephen Mark Cone director | AGrant or award Deferred Settlement RSUderivative | +31,481 | $0.00 | $0 | 69,822 | May 13, 2026 |
| May 12, 2026 | Dana Lynn Jacoby director | AGrant or award Deferred Settlement RSUderivative | +37,777 | $0.00 | $0 | 59,364 | May 13, 2026 |
| May 12, 2026 | Marc D Beer Executive Chairman | AGrant or award Stock Option (Right to Buy)derivative | +195,000 | $0.00 | $0 | 195,000 | May 13, 2026 |
| May 12, 2026 | Richard R Barrera director, owner | AGrant or award Stock Option (Right to Buy)derivative | +121,452 | $0.00 | $0 | 121,452 | May 13, 2026 |
| May 12, 2026 | Debra L Morris director | MOption exercise Class A Common Stock | +21,407 | - | - | 71,562 | May 13, 2026 |
| May 12, 2026 | Stephen Mark Cone director | AGrant or award Stock Option (Right to Buy)derivative | +130,000 | $0.00 | $0 | 130,000 | May 13, 2026 |
| May 12, 2026 | Dana Lynn Jacoby director | AGrant or award Stock Option (Right to Buy)derivative | +130,000 | $0.00 | $0 | 130,000 | May 13, 2026 |
| May 12, 2026 | Debra L Morris director | MOption exercise Deferred Settlement RSUderivative | -21,407 | $0.00 | $0 | 0 | May 13, 2026 |
| May 12, 2026 | Debra L Morris director | AGrant or award Deferred Settlement RSUderivative | +39,036 | $0.00 | $0 | 39,036 | May 13, 2026 |
| May 12, 2026 | Debra L Morris director | AGrant or award Stock Option (Right to Buy)derivative | +130,000 | $0.00 | $0 | 130,000 | May 13, 2026 |
| May 1, 2026 | Daniel Michael Monico General Counsel | AGrant or award Employee Stock Option (Right to Buy)derivative | +88,800 | $0.00 | $0 | 88,800 | May 4, 2026 |
| Apr 1, 2026 | Bret Christensen Chief Executive Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +441,653 | $0.00 | $0 | 441,653 | Apr 3, 2026 |
| Apr 1, 2026 | Robert Charles Peterson Chief Financial Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +107,169 | $0.00 | $0 | 107,169 | Apr 3, 2026 |
| Jun 9, 2025 | Richard R Barrera director, owner | AGrant or award Stock Option (right to buy)derivative | +150,439 | $0.00 | $0 | 150,439 | Jun 11, 2025 |
| May 13, 2025 | Debra L Morris director | MOption exercise Class A Common Stock | +11,045 | - | - | 50,155 | May 15, 2025 |
| May 13, 2025 | Debra L Morris director | MOption exercise Deferred Settlement RSUderivative | -11,045 | $0.00 | $0 | 0 | May 15, 2025 |
| May 13, 2025 | Debra L Morris director | AGrant or award Deferred Settlement RSUderivative | +21,407 | $0.00 | $0 | 21,407 | May 15, 2025 |
| May 13, 2025 | Debra L Morris director | AGrant or award Stock Option (Right to Buy)derivative | +104,547 | $0.00 | $0 | 104,547 | May 15, 2025 |
| May 13, 2025 | Andrew R Heyer director | AGrant or award Deferred Settlement RSUderivative | +20,687 | $0.00 | $0 | 46,123 | May 14, 2025 |
| May 13, 2025 | Stephen Mark Cone director | AGrant or award Deferred Settlement RSUderivative | +17,989 | $0.00 | $0 | 38,341 | May 14, 2025 |
| May 13, 2025 | Steven J Heyer director | AGrant or award Stock Option (Right to Buy)derivative | +104,547 | $0.00 | $0 | 104,547 | May 14, 2025 |
| May 13, 2025 | Dana Lynn Jacoby director | MOption exercise Class A Common Stock | +12,994 | - | - | 63,964 | May 14, 2025 |
| May 13, 2025 | Stephen Mark Cone director | AGrant or award Stock Option (Right to Buy)derivative | +104,547 | $0.00 | $0 | 104,547 | May 14, 2025 |
| May 13, 2025 | Andrew R Heyer director | AGrant or award Stock Option (Right to Buy)derivative | +104,547 | $0.00 | $0 | 104,547 | May 14, 2025 |
| May 13, 2025 | Dana Lynn Jacoby director | MOption exercise Deferred Settlement RSUderivative | -12,994 | $0.00 | $0 | 0 | May 14, 2025 |
| May 13, 2025 | Dana Lynn Jacoby director | AGrant or award Deferred Settlement RSUderivative | +21,587 | $0.00 | $0 | 21,587 | May 14, 2025 |
| May 13, 2025 | Dana Lynn Jacoby director | AGrant or award Stock Option (Right to Buy)derivative | +104,547 | $0.00 | $0 | 104,547 | May 14, 2025 |
| May 6, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See Footnote | +436,037 | $3.26 | $1.4M | 4,611,071 | May 8, 2025 |
| May 7, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See Footnote | +11,677 | $3.35 | $39k | 4,622,748 | May 8, 2025 |
| Apr 30, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +1,933 | $3.30 | $6,371 | 4,175,034 | May 2, 2025 |
| Apr 21, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +8,801 | $3.27 | $29k | 4,173,101 | Apr 23, 2025 |
| Apr 16, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: Footnote | +1,000 | $3.29 | $3,292 | 4,157,426 | Apr 18, 2025 |
| Apr 17, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: Footnote | +6,874 | $3.29 | $23k | 4,164,300 | Apr 18, 2025 |
| Apr 8, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +34,907 | $3.21 | $112k | 4,142,894 | Apr 10, 2025 |
| Apr 9, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +13,532 | $3.21 | $43k | 4,156,426 | Apr 10, 2025 |
| Apr 3, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +7,321 | $3.24 | $24k | 4,040,868 | Apr 7, 2025 |
| Apr 4, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +23,741 | $3.24 | $77k | 4,064,609 | Apr 7, 2025 |
| Apr 7, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +43,378 | $3.15 | $137k | 4,107,987 | Apr 7, 2025 |
| Mar 13, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +750,000 | $3.22 | $2.4M | 3,820,938 | Apr 3, 2025 |
| Mar 14, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +106,509 | $3.50 | $372k | 3,927,447 | Apr 3, 2025 |
| Mar 17, 2025 | Guines LLC owner | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +100 | $3.74 | $374 | 3,927,547 | Apr 3, 2025 |
| Apr 1, 2025 | Marc D Beer Executive Chairman | AGrant or award Employee Stock Option (Right to Buy)derivative | +495,600 | $0.00 | $0 | 495,600 | Apr 2, 2025 |
| Apr 1, 2025 | Mary Elizabeth Conlon General Counsel | AGrant or award Employee Stock Option (Right to Buy)derivative | +178,000 | $0.00 | $0 | 178,000 | Apr 2, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Richard R Barreraowner, director
- Marc D BeerExecutive Chairman
- Bret ChristensenChief Executive Officer
- Stephen Mark Conedirector
- Mary Elizabeth ConlonGeneral Counsel
- Guines LLCowner
- Andrew R Heyerdirector
- Steven J Heyerdirector
- Dana Lynn Jacobydirector
- Debra L Morrisdirector
- Daniel Michael MonicoGeneral Counsel
- Robert Charles PetersonInterim CEO
Questions about BTMD
Answered from the filings on this page, as of the latest one.
Are insiders buying BTMD?
As of Aug 12, 2026, SEC Form 4 filings show 1 open-market buy worth $202k by 1 insider and 0 open-market sells worth $0 by 0 insiders at biote Corp. in the last 90 days, net +$202k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade BTMD on the open market?
Marc D Beer (Executive Chairman) bought $202k of BTMD on Aug 10, 2026 and filed the Form 4 on Aug 12, 2026. InsiderTell scored 50 (moderate).
How many insiders file Form 4 at biote Corp.?
12 people have filed a Form 4 at biote Corp., among them Richard R Barrera (10% owner and director), Marc D Beer (Executive Chairman), Bret Christensen (Chief Executive Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.